BMRN

  • Last Update

  • Change

  • Volume / Avg.

  • Prev. Close

Today's Performance

52-Week Range

Biomarin Pharmaceutical, Inc.

Biomarin Pharmaceutical, Inc., develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of four product candidates Naglazyme, Kuvan, Aldurazyme and Firdapse.